95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-75.96%
Negative revenue growth while RGLD stands at 2.04%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-75.96%
Negative gross profit growth while RGLD is at 6.24%. Joel Greenblatt would examine cost competitiveness or demand decline.
-97.83%
Negative EBIT growth while RGLD is at 4.22%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-97.83%
Negative operating income growth while RGLD is at 4.22%. Joel Greenblatt would press for urgent turnaround measures.
182.08%
Net income growth at 50-75% of RGLD's 272.23%. Martin Whitman would question fundamental disadvantages in expenses or demand.
183.33%
EPS growth at 50-75% of RGLD's 300.00%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
183.33%
Diluted EPS growth at 50-75% of RGLD's 300.00%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
28.32%
OCF growth under 50% of RGLD's 63.70%. Michael Burry might suspect questionable revenue recognition or rising costs.
28.32%
FCF growth under 50% of RGLD's 64.50%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
6.51%
10Y revenue/share CAGR under 50% of RGLD's 1514.18%. Michael Burry would suspect a lasting competitive disadvantage.
6.51%
5Y revenue/share CAGR under 50% of RGLD's 20.79%. Michael Burry would suspect a significant competitive gap or product weakness.
6.51%
3Y revenue/share CAGR under 50% of RGLD's 813.04%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-28.03%
Firm’s AR is declining while RGLD shows 9.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
3.80%
Inventory growth of 3.80% while RGLD is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
-2.62%
Negative asset growth while RGLD invests at 8.90%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-0.62%
We have a declining book value while RGLD shows 8.34%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
339.85%
SG&A growth well above RGLD's 37.30%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.